Identification of genes associated with sensitivity to 5-flourouracil and cisplatin in hepatoma cells

Journal of Gastroenterology

Volumn 37, Issue SUPPL. 14, 2002, Pages 92-95

  Hoshida, Yujin ^a   Moriyama, Masaru ^a   Otsuka, Motoyuki ^a,b   Kato, Naoya ^a   Goto, Tadashi ^a   Taniguchi, Hiroyoshi ^a   Shiratori, Yasushi ^a   Seki, Naohiko ^b   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Helix Research Institute   (Japan)

Author keywords

5 fluorouracil; Chemosensitivity; Cisplatin; Gene expression

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CISPLATIN; COMPLEMENTARY DNA; FLUOROURACIL;

ARTICLE; CELL CYCLE; CHEMOSENSITIVITY; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFICACY; ENZYME METABOLISM; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC CODE; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR CELL LINE;

EID: 0036854730     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03326423     Document Type: Article

References (9)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.
2. Okuda K. Epidemiology. In: Livraghi T, Makuuchi M, Buscarini L, editors. Diagnosis and treatment of hepatocellular carcinoma. London: Greenwich Medical Media; 1997. p. 3-16.
3. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso M del C, Sala M, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999;29:62-7.
4. Hoshida Y, Shiratori Y, Omata M. Difficulties in conducting controlled trials in radical therapies for nonadvanced hepatocellular carcinoma. Hepatology 2000;32:877-80.
5. Carr BI. Chemotherapy. In: Livraghi T, Makuuchi M, Buscarini L, editors. Diagnosis and treatment of hepatocellular carcinoma. London: Greenwich Medical Media; 1997. p. 367-91.
6. Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays. Nat Genet 1999;21:33-7.
7. Yoshikawa T, Nagasugi Y, Azuma T, Kato M, Sugano S, Hashimoto K, et al. Isolation of novel mouse genes differentially expressed in brain using cDNA microarray. Biochem Biophys Res Commun 2000;275:532-7.
8. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001;344:539-48.
9. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, et al. A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000;24:236-44.